Celldex Therapeutics CLDX reported its Q4 earnings results on Monday, February 26, 2024 at 07:01 AM.
Here's what investors need to know about the announcement.
Earnings
Celldex Therapeutics missed estimated earnings by -12.0%, reporting an EPS of $-0.83 versus an estimate of $-0.74.
Revenue was up $2.52 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.13 which was followed by a 8.0% increase in the share price the next day.
Here's a look at Celldex Therapeutics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.68 | -0.67 | -0.63 | -0.59 |
EPS Actual | -0.81 | -0.65 | -0.62 | -0.56 |
Revenue Estimate | 580K | 530K | 410K | 260K |
Revenue Actual | 1.52M | 268K | 967K | 1.61M |
To track all earnings releases for Celldex Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.